Synthera R&D
Synthera R&D is a Montreal-based biotechnology company focused on the discovery and development of synergistic anti-cancer therapeutics.
We identify, validate, and advance novel drug combinations that maximize efficacy while minimizing toxicity.
Our proprietary approach leverages redox-targeted strategies. We exploit cancer-specific vulnerabilities to synergistically inhibit the antioxidant systems and selectively induce tumor cytotoxicity.
Synthera R&D is committed to transforming cancer treatment with breakthrough precision-calibrated synergistic therapies.
